您当前所在的位置:首页 > 产品中心 > 产品信息
TUG-424_分子结构_CAS_1082058-99-8)
点击图片或这里关闭

TUG-424

产品号 T6829 公司名称 Sigma Aldrich
CAS号 1082058-99-8 公司网站 http://www.sigmaaldrich.com
分子式 C18H16O2 电 话 1-800-521-8956
分子量 264.31844 传 真
纯 度 ≥98% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154377

产品价格信息

请登录

产品别名

标题
TUG-424
IUPAC标准名
3-{4-[2-(2-methylphenyl)ethynyl]phenyl}propanoic acid
IUPAC传统名
3-{4-[2-(2-methylphenyl)ethynyl]phenyl}propanoic acid
别名
3-(4-(o-Tolylethynyl)phenyl)propanoic acid

产品登记号

CAS号 1082058-99-8
MDL号 MFCD12912449

产品性质

Empirical Formula (Hill Notation) C18H16O2
纯度 ≥98% (HPLC)
溶解度 DMSO: >10 mg/mL
溶解度 H2O: insoluble
GHS危险品标识 GHS07
GHS危险品标识 GHS09
GHS警示词 Warning
GHS危险声明 H319-H410
欧盟危险性物质标志 刺激性(Irritant) 刺激性(Irritant) (Xi)
欧盟危险性物质标志 环境危害性(Nature polluting) 环境危害性(Nature polluting) (N)
MSDS下载 下载链接
个人保护装置 dust mask type N95 (US), Eyeshields, Gloves
GHS警示性声明 P273-P305 + P351 + P338-P501
RID/ADR UN 3077 9/PG 3
危险公开号 36-50/53
安全公开号 26-60-61
保存温度 2-8°C
联合国危险货物等级 9
联合国危险货物编号 3077
联合国危险货物包装类别(PG) 3
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
TUG-424 is expected to be useful in the exploration of FFA1 and may also be valuable as a lead structure for new potential antidiabetic therapeutics. TUG-424 significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA1 in metabolic diseases such as diabetes or obesity. It enhanced glucose-stimulated insulin secretion in a rat beta-cell line already at 100 nM and from isolated mouse islets through FFA1.GPR40 (now FFA1) was formerly an orphan GPCR whose endogenous ligands have recently been identified as free fatty acids (FFAs). The receptor appears to be involved in the pathophysiology of type 2 diabetes and is a drug target because of its role in FFA-mediated enhancement of glucose-stimulated insulin release.
详细说明 (简体中文)
Biochem/physiol Actions
TUG-424 is expected to be useful in the exploration of FFA1 and may also be valuable as a lead structure for new potential antidiabetic therapeutics. TUG-424 significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA1 in metabolic diseases such as diabetes or obesity. It enhanced glucose-stimulated insulin secretion in a rat beta-cell line already at 100 nM and from isolated mouse islets through FFA1.GPR40 (now FFA1) was formerly an orphan GPCR whose endogenous ligands have recently been identified as free fatty acids (FFAs). The receptor appears to be involved in the pathophysiology of type 2 diabetes and is a drug target because of its role in FFA-mediated enhancement of glucose-stimulated insulin release.

参考文献